These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Germline DDX41 mutations define a significant entity within adult MDS/AML patients. Sébert M; Passet M; Raimbault A; Rahmé R; Raffoux E; Sicre de Fontbrune F; Cerrano M; Quentin S; Vasquez N; Da Costa M; Boissel N; Dombret H; Peffault de Latour R; Socié G; Itzykson R; Fenaux P; Soulier J; Adès L; Clappier E Blood; 2019 Oct; 134(17):1441-1444. PubMed ID: 31484648 [TBL] [Abstract][Full Text] [Related]
8. The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms. Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang HY; Murray SS; Vagher J; Kovacsovics T; Patel JL Blood; 2022 Aug; 140(7):716-755. PubMed ID: 35671390 [TBL] [Abstract][Full Text] [Related]
10. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Makishima H; Saiki R; Nannya Y; Korotev S; Gurnari C; Takeda J; Momozawa Y; Best S; Krishnamurthy P; Yoshizato T; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Nagata Y; Kakiuchi N; Onizuka M; Chiba K; Tanaka H; Kon A; Ochi Y; Nakagawa MM; Okuda R; Mori T; Yoda A; Itonaga H; Miyazaki Y; Sanada M; Ishikawa T; Chiba S; Tsurumi H; Kasahara S; Müller-Tidow C; Takaori-Kondo A; Ohyashiki K; Kiguchi T; Matsuda F; Jansen JH; Polprasert C; Blombery P; Kamatani Y; Miyano S; Malcovati L; Haferlach T; Kubo M; Cazzola M; Kulasekararaj AG; Godley LA; Maciejewski JP; Ogawa S Blood; 2023 Feb; 141(5):534-549. PubMed ID: 36322930 [TBL] [Abstract][Full Text] [Related]
11. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909 [TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations. Qu S; Li B; Qin T; Xu Z; Pan L; Hu N; Huang G; Peter Gale R; Xiao Z Br J Haematol; 2021 Mar; 192(6):1006-1010. PubMed ID: 32307695 [TBL] [Abstract][Full Text] [Related]
13. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Polprasert C; Schulze I; Sekeres MA; Makishima H; Przychodzen B; Hosono N; Singh J; Padgett RA; Gu X; Phillips JG; Clemente M; Parker Y; Lindner D; Dienes B; Jankowsky E; Saunthararajah Y; Du Y; Oakley K; Nguyen N; Mukherjee S; Pabst C; Godley LA; Churpek JE; Pollyea DA; Krug U; Berdel WE; Klein HU; Dugas M; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Yoshida K; Ogawa S; Müller-Tidow C; Maciejewski JP Cancer Cell; 2015 May; 27(5):658-70. PubMed ID: 25920683 [TBL] [Abstract][Full Text] [Related]
14. A novel bi-alleleic DDX41 mutations in B-cell lymphoblastic leukemia: case report. Shin WY; Yoon SY; Park R; Kim JA; Song HH; Bang HI; Won JH; Kim J BMC Med Genomics; 2022 Mar; 15(1):46. PubMed ID: 35246110 [TBL] [Abstract][Full Text] [Related]
15. Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms. Badar T; Chlon T Curr Hematol Malig Rep; 2022 Oct; 17(5):113-120. PubMed ID: 35781188 [TBL] [Abstract][Full Text] [Related]
16. VEXAS syndrome in a patient with DDX41 germline predisposition syndrome. Kusne Y; Lasho T; Finke C; Patnaik MM; Badar T Leuk Res; 2024 Jan; 136():107432. PubMed ID: 38159331 [No Abstract] [Full Text] [Related]
17. Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome. Al-Kali A; Nanaa A; Viswanatha D; He R; Nguyen P; Jevremovic D; Foran JM; Yi CA; Greipp PT; Gangat N; Patnaik M; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Badar T; Alkhateeb HB Blood Cancer J; 2023 Apr; 13(1):49. PubMed ID: 37032414 [No Abstract] [Full Text] [Related]
18. Clinical and mechanistic insights into the roles of DDX41 in haematological malignancies. Weinreb JT; Bowman TV FEBS Lett; 2022 Nov; 596(21):2736-2745. PubMed ID: 36036093 [TBL] [Abstract][Full Text] [Related]